| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 6, 1479-1488, Copyright © 1992 by Endocrine Society
ARTICLES |
J Wang and S Chen
Division of Immunology, Beckman Research Institute of the City of the Hope Duarte, California 91010.
Aromatase, a cytochrome P-450, catalyzes the formation of aromatic C18 estrogenic steroids from C19 androgens. DNA sequence analysis of the human aromatase gene has revealed that a putative promoter sequence exists immediately up-stream of the second exon. Chloramphenicol acetyltransferase functional analyses of cells transfected with chloramphenicol acetyltransferase expression plasmids containing various DNA fragments derived from the 3'-end of the first intron of the aromatase gene were performed to show that a promoter indeed exists in this region. However, in all of the cell lines used in this study, MCF-7, JAR, OVCAR-3, and skin fibroblast, the function of this promoter was inhibited by a negative regulatory element situated up-stream from the promoter. The results further suggest that this inhibitory element behaves as a silencer element, in that it could inhibit a simian virus- 40 promoter from a distance of several kilobases. This negative element worked in both orientations and inhibited the functions of several promoters, including the newly identified promoter situated in the 3'- end of the first intron of the human aromatase gene. Primer extension analysis has been performed to determine the potential transcription start site. The mechanism of the regulation of aromatase expression is known to be very complex. The presence of a promoter and a silencer at the 3'-end of the first intron may represent one additional way that aromatase expression is controlled in estrogen-producing cells.
This article has been cited by other articles:
![]() |
T. Okubo, T. K. Truong, B. Yu, T. Itoh, J. Zhao, B. Grube, D. Zhou, and S. Chen Down-Regulation of Promoter I.3 Activity of the Human Aromatase Gene in Breast Tissue by Zinc-finger Protein, Snail (SnaH) Cancer Res., February 1, 2001; 61(4): 1338 - 1346. [Abstract] [Full Text] |
||||
![]() |
D. Zhou, K. M. Quach, C. Yang, S. Y. Lee, B. Pohajdak, and S. Chen PNRC: A Proline-Rich Nuclear Receptor Coregulatory Protein That Modulates Transcriptional Activation of Multiple Nuclear Receptors Including Orphan Receptors SF1 (Steroidogenic Factor 1) and ERR{alpha}1 (Estrogen Related Receptor {alpha}-1) Mol. Endocrinol., July 1, 2000; 14(7): 986 - 998. [Abstract] [Full Text] |
||||
![]() |
C. A. Stratakis, A. Vottero, A. Brodie, L. S. Kirschner, D. DeAtkine, Q. Lu, W. Yue, C. S. Mitsiades, A. W. Flor, and G. P. Chrousos The Aromatase Excess Syndrome Is Associated with Feminization of Both Sexes and Autosomal Dominant Transmission of Aberrant P450 Aromatase Gene Transcription J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1348 - 1357. [Abstract] [Full Text] |
||||
![]() |
D. Zhou, P. Clarke, J. Wang, and S. Chen Identification of a Promoter That Controls Aromatase Expression in Human Breast Cancer and Adipose Stromal Cells J. Biol. Chem., June 21, 1996; 271(25): 15194 - 15202. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |